Patents by Inventor Yong Bok Seo

Yong Bok Seo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL VACCINE ADJUVANT
    Publication number: 20240016925
    Abstract: There is provided a novel vaccine adjuvant, and more specifically, a vaccine adjuvant for stimulating a T lymphocyte-specific immune response, which includes an IL-12 protein and an IL-21 protein as active ingredients, or includes the polynucleotide encoding an IL-12 protein and the polynucleotide encoding an IL-21 protein as active ingredients.
    Type: Application
    Filed: August 4, 2023
    Publication date: January 18, 2024
    Applicant: SL VAXIGEN, INC.
    Inventors: Yong Bok SEO, Youngwoo CHOI, Sang Hee SIM
  • Vaccine adjuvant
    Patent number: 11844834
    Abstract: There is provided a novel vaccine adjuvant, and more specifically, a vaccine adjuvant for stimulating a T lymphocyte-specific immune response, which includes an IL-12 protein and an IL-21 protein as active ingredients, or includes the polynucleotide encoding an IL-12 protein and the polynucleotide encoding an IL-21 protein as active ingredients.
    Type: Grant
    Filed: January 30, 2019
    Date of Patent: December 19, 2023
    Assignee: SL VAXIGEN, INC.
    Inventors: Yong Bok Seo, Youngwoo Choi, Sang Hee Sim
  • A NOVEL VACCINE ADJUVANT
    Publication number: 20200360514
    Abstract: There is provided a novel vaccine adjuvant, and more specifically, a vaccine adjuvant for stimulating a T lymphocyte-specific immune response, which includes an IL-12 protein and an IL-21 protein as active ingredients, or includes the polynucleotide encoding an IL-12 protein and the polynucleotide encoding an IL-21 protein as active ingredients.
    Type: Application
    Filed: January 30, 2019
    Publication date: November 19, 2020
    Applicant: SL VAXIGEN, INC.
    Inventors: Yong Bok SEO, Youngwoo CHOI, Sang Hee SIM
  • Gene vaccine for preventing and treating severe fever with thrombocytopenia syndrome
    Publication number: 20190231862
    Abstract: Provided is a gene vaccine composition for preventing and treating severe fever with thrombocytopenia syndrome (SFTS), including, as an active ingredient, at least one expression vector including a first polynucleotide encoding a glycoprotein N (Gn) derived from SFTS virus, a second polynucleotide encoding a glycoprotein C (Gc), a third polynucleotide encoding a nucleocapsid protein (NP) derived from the SFTS virus, and a fourth polynucleotide encoding a nonstructural protein (NS) derived from the SFTS virus.
    Type: Application
    Filed: October 16, 2018
    Publication date: August 1, 2019
    Inventors: Hyun-Tak Jin, Yong Bok Seo, Ju-A Shin